Joypride 400mg Tablet contains Amisulpride, an atypical antipsychotic agent primarily indicated for the treatment of schizophrenia and other psychotic disorders. Amisulpride exerts its therapeutic effects by selectively antagonizing dopamine D2 and D3 receptors in the central nervous system, thereby modulating dopaminergic neurotransmission implicated in psychotic symptoms. This medication is effective in managing both positive symptoms, such as hallucinations and delusions, and negative symptoms, including social withdrawal and apathy. Joypride 400mg Tablet is typically administered orally, with dosage individualized based on clinical response and tolerability. Common adverse effects may include extrapyramidal symptoms, hyperprolactinemia, sedation, and gastrointestinal disturbances. Caution is advised in patients with a history of cardiac arrhythmias, as Amisulpride has the potential to prolong the QT interval. Regular monitoring of cardiac function, blood glucose, and prolactin levels is recommended during therapy. The use of Joypride should be carefully evaluated in populations such as the elderly, pregnant or breastfeeding women, and those with renal or hepatic impairment. Discontinuation should be gradual to minimize withdrawal symptoms and relapse risk. This medication should be prescribed and supervised by a qualified healthcare professional to ensure optimal therapeutic outcomes and patient safety.